Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors
Open accessAbstract
The mesostriatal dopaminergic system influences locomotor activity and the reinforcing properties of many drugs of abuse including nicotine. Here we investigate the role of the alpha4 nicotinic acetylcholine receptor (nAChR) subunit in mediating the effects of nicotine in the mesolimbic dopamine system in mice lacking the alpha4 subunit. We show that there are two distinct populations of receptors in the substantia nigra and striatum by using autoradiographic labelling with 125I alpha-conotoxin MII. These receptors are comprised of the alpha4, beta2 and alpha6 nAChR subunits and non-alpha4, beta2, and alpha6 nAChR subunits. Non-alpha4 subunit-containing nAChRs are located on dopaminergic neurons, are functional and respond to nicotine as demonstrated by patch clamp recordings. In vivo microdialysis performed in awake, freely moving mice reveal that mutant mice have basal striatal dopamine levels which are twice as high as those observed in wild-type mice. Despite the fact that both wild-type and alpha4 null mutant mice show a similar increase in dopamine release in response to intrastriatal KCl perfusion, a nicotine-elicited increase in dopamine levels is not observed in mutant mice. Locomotor activity experiments show that there is no difference between wild-type and mutant mice in basal activity in both habituated and non-habituated environments. Interestingly, mutant mice sustain an increase in cocaine-elicited locomotor activity longer than wild-type mice. In addition, mutant mice recover from depressant locomotor activity in response to nicotine at a faster rate. Our results indicate that alpha4-containing nAChRs exert a tonic control on striatal basal dopamine release, which is mediated by a heterogeneous population of nAChRs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
β2* nAChRs are necessary for nicotine self-administration, DA-dependent locomotor activation, nicotine-associated enhancement of NAc DA release, and nicotine-associated enhancement of conditioned reinforcement.
“Studies in β2* nAChR null mutant mice further show that β2* nAChRs are necessary for nicotine self-administration, DA-dependent locomotor activation, nicotine-associated enhancement of NAc DA release, and nicotine-associated enhancement of conditioned reinforcement (Brunzell et al., 2006; King et al., 2004; Marubio et al., 2003; Picciotto et al., 1998).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Marubio et al., 2003
Mice lacking α4, α6, and/or β2 nAChR subunits do not self-administer nicotine, and restoring these subunits in the ventral tegmental area of knockout mice restores nicotine self-administration.
“Evidence for this idea stemmed from studies showing that mice lacking the ␣4, ␣6, and/or 2 nAChR subunits fail to self-administer nicotine, whereas re-expression of these subunits in the ventral tegmental area of knockout mice restored nicotine self-administration”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Marubio et al., 2003
β2, α4, or α6 nAChR knockout mice fail to self-administer nicotine.
“extensive studies showing that 2, ␣4, or ␣6 nAChRs knockout mice fail to self-administer nicotine (Picciotto et al., 1998;Marubio et al., 2003;Maskos et al., 2005;Pons et al., 2008).”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Marubio et al., 2003
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258 · see citing works
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Self-citationEffects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · see citing works
Clarke, P. B. S., Schwartz, R., Paul, S. M., Cb, P., & Pert, A. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01307.1985 · Cited by 1,037 · see citing works
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829 · see citing works
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769 · see citing works
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · see citing works
Long-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720 · see citing works
Kelly, P. H., & Iversen, S. D. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90352-6 · Cited by 712 · see citing works
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674 · see citing works
Self-citationThe origins of cholinergic and other subcortical afferents to the thalamus in the rat
Hallanger, A. E., Levey, A. I., Lee, H. J., Rye, D. B., & Wainer, B. H. (1987) · The Journal of Comparative Neurology · doi:10.1002/cne.902620109 · Cited by 595 · see citing works
Alkondon, M., & Albuquerque, E. X. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38283-2 · Cited by 538 · see citing works
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 533 · see citing works
Self-citationA New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489 · see citing works
Self-citationIdentification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 401 · see citing works
Self-citationFunctional contributions of α5 subunit to neuronal acetylcholine receptor channels
Ramírez-Latorre, J. A., Yu, C., Qu, X., Perin, F., Karlin, A., & Role, L. W. (1996) · Nature · doi:10.1038/380347a0 · Cited by 397 · see citing works
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387 · see citing works
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · see citing works
Self-citationOakman, S., Faris, P. L., Kerr, P., Cozzari, C., & Hartman, B. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-09-05859.1995 · Cited by 384 · see citing works
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350 · see citing works
Champtiaux, N., Han, Z., Bessis, A., Rossi, F., Zoli, M., Marubio, L. M., McIntosh, J. M., & Changeux, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345 · see citing works
Self-citationHallanger, A. E., & Wainer, B. H. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902740403 · Cited by 343 · see citing works
Clarke, P. B., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22152-8 · Cited by 318 · see citing works
Selective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 276 · see citing works
Forster, G. L., & Blaha, C. D. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00250.x · Cited by 271 · see citing works
Nicotine self-administration in animals and humans: similarities and differences
Rose, J. E., & Corrigall, W. A. (1997) · Psychopharmacology · doi:10.1007/s002130050209 · Cited by 262 · see citing works
Acute and chronic tolerance to nicotine measured by activity in rats
Stolerman, I. P., Fink, R. S., & Jarvik, M. E. (1973) · Psychopharmacology · doi:10.1007/bf00429192 · Cited by 247 · see citing works
Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses
Kuryatov, A., Olale, F., Cooper, J., Choi, C. H., & Lindstrom, J. M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00144-1 · Cited by 223 · see citing works
Blaha, C. D., Allen, L., Das, S., Inglis, W. L., LATIMER, M. L., Vincent, S., & Winn, P. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00714.1996 · Cited by 216 · see citing works
Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204 · see citing works
Bevan, M. D., & Bolam, J. P. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07105.1995 · Cited by 203 · see citing works
Parker, M. J., Beck, A., & Luetje, C. W. (1998) · PubMed · Cited by 165 · see citing works
Neuronal Nicotinic Receptor β2 and β4 Subunits Confer Large Differences in Agonist Binding Affinity
Parker, M. J., Beck, A., & Luetje, C. W. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1132 · Cited by 161 · see citing works
Lee, H. J., Rye, D. B., Hallanger, A. E., Levey, A. I., & Wainer, B. H. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902750402 · Cited by 159 · see citing works
Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · PubMed · Cited by 158 · see citing works
Self-citationIkemoto, S., Kohl, R. R., & McBride, W. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010137.x · Cited by 155 · see citing works
Involvement of the α3 Subunit in Central Nicotinic Binding Populations
Whiteaker, P., Peterson, C. G., Xu, W., McIntosh, J. M., Paylor, R. E., Beaudet, A. L., Collins, A. C., & Marks, M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02522.2002 · Cited by 145 · see citing works
Self-citationDifferential Agonist Inhibition Identifies Multiple Epibatidine Binding Sites in Mouse Brain
Marks, M. J., Smith, K. W., & Collins, A. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37384-7 · Cited by 140 · see citing works
Sivilotti, L. G., Mcneil, D. K., Lewis, T., Nassar, M. A., Schoepfer, R., & Colquhoun, D. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp022004 · Cited by 126 · see citing works
Nicotine tolerance in rats; role of dose and dose interval
Stolerman, I. P., Bunker, P., & Jarvik, M. E. (1974) · Psychopharmacology · doi:10.1007/bf00422555 · Cited by 121 · see citing works
“Orphan” α6 Nicotinic AChR Subunit Can Form a Functional Heteromeric Acetylcholine Receptor
Gerzanich, V., Kuryatov, A., Anand, R., & Lindstrom, J. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.320 · Cited by 118 · see citing works
Arroyo-Jiménez, M. D. M., Bourgeois, J.-P., Marubio, L. M., Le Sourd, A.-M., Ottersen, O. P., Rinvik, E., Fairén, A., & Changeux, J.-P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06475.1999 · Cited by 110 · see citing works
Self-citationNicola, S. M., & Deadwyler, S. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05526.2000 · Cited by 100 · see citing works
Groot‐Kormelink, P. J., Luyten, W. H. M. L., Colquhoun, D., & Sivilotti, L. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15317 · Cited by 100 · see citing works
Single channel properties of human α3 AChRs: impact of β2, β4 and α5 subunits
Nelson, M. E., & Lindstrom, J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0657u.x · Cited by 92 · see citing works
Malagi�, I., Trillat, A.-C., Douvier, E., Anmella, M.-C., Dessalles, M. C., Jacquot, C., & Gardier, A. M. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00166906 · Cited by 56 · see citing works
Self-citationDiagnostic Criteria for Essential Tremor
Louis, E. D., Ford, B., Lee, H., Andrews, H., & Cameron, G. (1998) · Archives of Neurology · doi:10.1001/archneur.55.6.823
Flagged first, then by citations
Cited by
Sorted by citations
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686 · see citing works
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533 · see citing works
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · see citing works
Self-citationPICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Rollema, H., Coe, J. W., Chambers, L. K., Hurst, R. S., Stahl, S. M., & Williams, K. E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.003 · Cited by 400 · see citing works
Nicotine as a modulator of behavior: beyond the inverted U
Picciotto, M. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00230-x · Cited by 257 · see citing works
Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5095-09.2010 · Cited by 226 · see citing works
Self-citationRollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00682.x · Cited by 162 · see citing works
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159 · see citing works
Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement
Tolu, S., Eddine, R., Marti, F., David, V, Graupner, M., Pons, S., Baudonnat, M., Husson, M., Besson, M., Reperant, C., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.83 · Cited by 151 · see citing works
Self-citationNguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148 · see citing works
Xiao, Y., Fan, H., Musachio, J. L., Wei, Z.-L., Chellappan, S. K., Kozikowski, A. P., & Kellar, K. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027318 · Cited by 141 · see citing works
Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2056-10.2010 · Cited by 127 · see citing works
Self-citationRole of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125 · see citing works
Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · see citing works
Hancock, D. B., Reginsson, G. W., Gaddis, N. C., Chen, X., Saccone, N. L., Lutz, S. M., Qaiser, B., Sherva, R., Steinberg, S., Zink, F., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.149 · Cited by 85 · see citing works
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81 · see citing works
Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77 · see citing works
Self-citationBrunzell, D. H., Chang, J. R., Schneider, B., Olausson, P., Taylor, J. R., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0099-z · Cited by 71 · see citing works
Bordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70 · see citing works
Self-citationStructural determinants of α4β2 nicotinic acetylcholine receptor trafficking
Ren, X.-Q., Cheng, S.-B., Treuil, M. W., Mukherjee, J., Rao, J., Braunewell, K. H., Lindstrom, J. M., & Anand, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1079-05.2005 · Cited by 61 · see citing works
Cholinergic modulation of dopamine pathways through nicotinic acetylcholine receptors
de Kloet, S. F., Mansvelder, H. D., & De Vries, T. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.014 · Cited by 69 · see citing works
Spiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58 · see citing works
Meyer, E. L., Yoshikami, D., & McIntosh, J. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05266.x · Cited by 58 · see citing works
Self-citationTapper, A. R., McKinney, S. L., Marks, M. J., & Lester, H. A. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00063.2007 · Cited by 40 · see citing works
Champtiaux, N., Kalivas, P. W., & Bardo, M. T. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.10.017 · Cited by 33 · see citing works
- Authors
- Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., & Changeux, J.
- Affiliations
- Institut Pasteur (FR)
- Université Paris-Sud (FR)
- University of Utah (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Marubio, L. M.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 17
- Issue
- 7
- Pages
- 1329-1337
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2011596780
- Cited by
- 242
- References
- 49
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 11 · 2016: 4 · 2015: 13 · 2014: 10 · 2013: 11 · 2012: 15
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Centre National de la Recherche Scientifique
- National Institutes of Health
- National Institute of Mental Health (MH53631)
- National Institute on Drug Abuse (1-P01-DA12661, R01DA012242, P01DA012661, DA12242)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotine, mesolimbic dopamine system, substantia nigra, striatum, striatal dopamine release, locomotor activity, alpha-conotoxin MII, dopaminergic neurons
- MeSH terms
- Animals, Autoradiography, Binding Sites, Dopamine, Dose-Response Relationship, Drug, Extracellular Space, Iodine Isotopes, Mice, Inbred C57BL, Motor Activity, Nicotine, Pyridines, Receptors, Nicotinic, Substantia Nigra, Time Factors, Mutagenesis, Neural Networks, Computer, Microdialysis, Ventral Tegmental Area, Mice, Knockout, Patch-Clamp Techniques, Nicotinic Agonists, Bridged Bicyclo Compounds, Heterocyclic, Conotoxins, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review